METHOD FOR PREDICTING CLINICAL COURSE OF NODULAR SCLEROSIS HODGKIN'S LYMPHOMA BY MORPHOMETRIC EVALUATION OF INDEX OF PROPORTION OF POSITIVE TUMOUR CELLS PD-L1 TO BCL2 IN LYMPH NODES
2023-08-04
专利权人KIROV RES INST HEMATOLOGY & BLOOD TRANSF (KIRO-Soviet Institute)
申请日期2023-08-04
专利号RU2828024-C1
成果简介NOVELTY - Invention refers to medicine, namely to haematology and pathological anatomy, and can be used for prediction of the clinical course of nodular sclerosis of Hodgkin's lymphoma. That is ensured by immunohistochemical staining after lymphadenectomy. Relative number of PD-L1- and BCL2-positive tumour cells is calculated using the developed mathematical formulas. Further, the index of the ID fraction is determined using a mathematical formula. If the ID is less than or equal to 73%, a favourable clinical course is predicted. If the ID is more than 73%, the unfavourable clinical course of the disease is predicted. USE - Medicine. ADVANTAGE - Invention allows predicting the clinical course of lymphoma of Hodgkin's lymphoma in patients after lymphadenectomy. 1 cl, 2 ex
IPC 分类号G01N-033/53
国家俄罗斯
专业领域生物科学
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/20971
专题中国科学院新疆生态与地理研究所
作者单位
KIROV RES INST HEMATOLOGY & BLOOD TRANSF (KIRO-Soviet Institute)
推荐引用方式
GB/T 7714
DYAKONOV D A,MINAEV M S,PERFILOVA E A. METHOD FOR PREDICTING CLINICAL COURSE OF NODULAR SCLEROSIS HODGKIN'S LYMPHOMA BY MORPHOMETRIC EVALUATION OF INDEX OF PROPORTION OF POSITIVE TUMOUR CELLS PD-L1 TO BCL2 IN LYMPH NODES. RU2828024-C1[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。